Advanced Enzyme Technologies Ltd Share Price Today - Advanced Enzyme Technologies Ltd Stock Price Live NSE/BSE

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES BSE: 540025

₹294.90

(1.10%)

Tue, 17 Mar 2026, 11:24 pm

MTF 5xInvest in Advanced Enzyme Technologies Ltd with 5x Leverage Buy with MTF

Market Cap32.71B

PE Ratio21.69

Dividend1.78

Consumer Non-Durables

Food: Specialty/Candy

24.5K

Advanced Enzyme Technologies Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
3069.03
Net Profit
133.97
P/B
2.20
Sector P/E
32.17
P/E
23.80
EV/EBITDA
13.35
Debt/Equity (Industry)
0.29
Interest Cover (Industry)
4.37
ROCE (Industry)
9.08
RONW (Industry)
6.98
ROE
9.76
ROCE
13.55
Debt/Equity
0.03
EPS (TTM)
12.86
Dividend Yield
1.90
Book Value
132.64
Interest Cover
41.47

Analysis

all

Pros

Advanced Enzyme Technologies's earnings growth is expected to exceed the low risk savings rate of 7.2%.
Advanced Enzyme Technologies's earnings are expected to exceed the low risk growth rate next year.
Performance (ROE) is expected to be above the current IN Chemicals industry average.
An improvement in Advanced Enzyme Technologies's performance (ROE) is expected over the next 3 years.
Advanced Enzyme Technologies's revenue growth is expected to exceed the India market average.

Cons

Advanced Enzyme Technologies is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
No need to calculate the sustainability of Advanced Enzyme Technologies's dividends as it is not paying a notable one for India.
Advanced Enzyme Technologies is not paying a notable dividend for India, therefore no need to check if the payments are stable.
Advanced Enzyme Technologies's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Advanced Enzyme Technologies's dividend is below the markets top 25% of dividend payers in India (3.08%).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	43.04	43.07	43.08	43.08	42.93
FII	25.86	25.41	23.46	11.90	12.58
DII	5.51	6.41	8.45	8.19	8.18
Public	25.59	25.10	25.02	36.83	36.32
Government	0	0	0	0	0

Technical Analysis

RSI

41.80

MACD

-3.80

50 DMA

291.69

200 DMA

313.52

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	413.23	353.03	326.67	292.83	266.47	232.63	172.43
Fibonacci	353.03	330.04	315.83	292.83	269.84	255.63	232.63
Camarilla	316.86	311.34	305.82	292.83	294.78	289.26	283.75

Pivots Level: Classic

+120.40

413.23

+60.20

353.03

+33.83

326.67

292.83

Pivot Point

LTP: 280.70

-26.37

266.47

-60.20

232.63

-120.40

172.43

Moving Average

SMAEMA

Period

Value

10-EMA
287.16
20-EMA
291.26
30-EMA
292.69
50-EMA
294.83
100-EMA
300.45
200-EMA
310.32

Announcement Date	Purpose	Action	Ex Date
31 Jan 2026	board-meetings	Quarterly Results
23 Jun 2025	dividend	Final Dividend - Rs. - 1.2	23 Jul 2025
13 May 2025	agm
13 May 2025	dividend	₹1.20 Dividend /Share	23 Jul 2025
17 Apr 2025	dividend	Interim Dividend - Rs. - 4	17 May 2025
16 Apr 2025	dividend	Interim Dividend - Rs 4 Per Share	17 May 2025
25 Jun 2024	agm
18 Jun 2024	dividend	Final Dividend - Rs. - 1.1	18 Jul 2024
11 May 2024	dividend	₹1.10 Dividend /Share	18 Jul 2024
18 Apr 2024	dividend	Interim Dividend - Rs. - 4	18 May 2024

Advanced Enzyme Technologies Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd

Cipla Ltd

Advanced Enzyme Technologies Ltd About

Advanced Enzyme Techs. is engaged in the business of manufacturing and sales of enzymes.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1989

Headquarters

CEO

VASANT RATHI

Employees

Contact

Website

http://www.advancedenzymes.com

sanjay@advancedenzymes.com; info@advancedenzymes.c

Phone

91-22-41703200

Location

Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi, Thane, Maharashtra, 400604

Year	History
2016	Advanced Enzyme Technologies were listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. Advanced Enzymes acquired a 70% stake in API maker JC Biotech. The Company was awarded by ABP News as 'The Best Nutraceutical Company of the Year'.
2017	The Company was awarded for 'BEST IPO' at IR Society Awards 2017. The Company acquired a 100% stake in the German-based company evoxx technologies GmbH.
2018	The Company acquired a 100% stake in SciTech Specialties Private Limited.
2023	Advanced Enzyme Technologies Limited acquired a 50% stake in Saiganesh Enzytech Solutions Private Limited and an additional 4.83% stake in JC Biotech Private Limited.
2024	Advanced Enzyme Technologies Limited acquired an additional stake of 5.89% in JC Biotech Private Limited.

Client Name	Order Side	QTY	Avg Price	Date
GRAVITON RESEARCH CAPITAL LLP	Buy	1007488	352.13	29 Aug 2025
GRAVITON RESEARCH CAPITAL LLP	Sell	1007488	352.61	29 Aug 2025
POLUNIN EMERGING MARKETS SMALL CAP FUND LLC	Buy	1250938	353.5	29 Aug 2025
GRAVITON RESEARCH CAPITAL LLP	Buy	821877	507.08	11 Sept 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	821877	507.35	11 Sept 2024
MOTILAL OSWAL FINANCIAL SERVICES LIMITED	Buy	11053245	385	19 Jun 2024
ORBIMED ASIA III MAURITIUS LIMITED	Sell	11053245	385	19 Jun 2024
GRAVITON RESEARCH CAPITAL LLP	Sell	723134	358.11	06 Dec 2023
GRAVITON RESEARCH CAPITAL LLP	Buy	723134	357.73	06 Dec 2023
ADVANCED VITAL ENZYMES PRIVATE LIMITED	Sell	618105	359.25	06 Dec 2023

Advanced Enzyme Technologies Ltd News

Advanced Enzyme Tech SVP Marketing Resigns

Advanced Enzyme Technologies announces resignation of Senior Vice President Marketing and Business Development Mr. Dipak Roda, effective April 09, 2026, in regulatory filing to stock exchanges.

11 Mar 2026

stocks

Advanced Enzyme Tech Gets AA- Credit Rating

ICRA assigns AA-(Stable)/A1+ credit ratings to Advanced Enzyme Technologies for ₹100 crore banking facilities across fund-based and non-fund based instruments.

13 Feb 2026

stocks

Advanced Enzyme Tech Opens Special Window for Share Transfer

Advanced Enzyme Technologies Ltd announces special window for transfer and dematerialization of physical shares, published in newspapers on February 10, 2026 under regulatory compliance.

11 Feb 2026

co actions results

Advanced Enzyme Tech Makes Q3FY26 Call Recording Available

Advanced Enzyme Technologies Limited has made the audio recording of its February 4, 2026 conference call discussing Q3FY26 unaudited financial results available on its website for investors and analysts.

04 Feb 2026

co actions results

Advanced Enzyme Tech Schedules Q3FY26 Results Call

Advanced Enzyme Technologies Ltd announces conference call on February 04, 2026 at 4:00 PM IST to discuss Q3FY26 unaudited financial results for quarter and nine months ended December 31, 2025.

28 Jan 2026

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800